SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.08-2.9%Dec 26 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (14756)12/17/2004 5:34:41 PM
From: Icebrg  Read Replies (1) of 52153
 
CTIC

They have stated that they expect to be able to raise at least 30 mUSD. Which is not very much considering their current burn rate.

I don't think the recently announced licensing arrangement is much to "bother" about. The company will either be very rich and famous or completely dead and forgotten before any drug from that product line will have reached its maturity.

This will by the way be NovusPharma's second try with the platinum drugs. The first time they didn't succeed.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News